RCC, RENAL CELL CANCER
Clinical trials for RCC, RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new RCC, RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for RCC, RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough kidney cancers: testing a powerful drug combo
Disease control Not yet recruitingThis study is testing a new combination of drugs for people with advanced kidney cancer that has worsened after their first treatment. It combines an immunotherapy (iparomlimab and tuvonralimab) with one of two targeted drugs (lenvatinib or axitinib). The main goal is to see if t…
Matched conditions: RCC, RENAL CELL CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Simple blood test could tell doctors which cancer patients will respond to immunotherapy
Diagnosis Not yet recruitingThis study aims to develop a blood test that predicts whether cancer patients will benefit from immunotherapy drugs. Researchers will analyze blood samples from 600 patients with lung cancer, melanoma, breast cancer, kidney cancer, or head/neck cancer before they start treatment.…
Matched conditions: RCC, RENAL CELL CANCER
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC